Overview: Dexamethasone TestIntroduction: The Dexamethasone Test measures dexamethasone levels to monitor treatment for adrenal disorders, reducing swelling or inflammation. Aligned with 2023 Endocrine Society guidelines, it uses an immunoassay for high sensitivity, aiding in drug monitoring. This test is critical for guiding dosing, treatment, and improving outcomes in toxicology for patients on dexamethasone therapy.
Other Names: Dexamethasone Assay, Steroid Monitoring Test.
FDA Status: Laboratory-developed test (LDT), meeting toxicology standards for diagnostic accuracy.
Historical Milestone: Dexamethasone testing began in the 1980s with steroid therapy research. Immunoassays emerged in the 1990s, and by the 2000s, high-sensitivity assays improved accuracy.
Purpose: Monitors dexamethasone levels, guides dosing, and prevents toxicity in patients with adrenal disorders or inflammation.
Test Parameters: 1. Dexamethasone
Pretest Condition: Fasting for 10-12 hours required to stabilize drug levels. Collect serum or plasma before the next dose. Report symptoms like swelling or fatigue, and list medications.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document swelling, fatigue, or history of adrenal disorders. Include current medications, especially steroids.
Consent: Written consent required, detailing the tests purpose, implications for dosing, and potential need for therapy adjustments.
Procedural Considerations: Uses an immunoassay to measure dexamethasone levels. Results are available in 3-5 days, enabling clinical decisions.
Factors Affecting Result Accuracy: Non-fasting or improper timing can affect results. Hemolysis may degrade samples.
Clinical Significance: Abnormal dexamethasone levels indicate need for dose adjustment to prevent toxicity or inefficacy. Therapeutic levels support ongoing monitoring.
Specialist Consultation: Consult an endocrinologist or rheumatologist for result interpretation.
Additional Supporting Tests: Cortisol levels, ACTH test, or adrenal imaging to monitor treatment effects.
Test Limitations: Results may vary with drug interactions. Clinical correlation is required.
References: Endocrine Society Adrenal Guidelines, 2023; Journal of Clinical Endocrinology, Nieman LK, 2022.
